The British Columbia Securities Commission is warning the public about Pegasus Pharmaceuticals Group Inc. (Pegasus) and its associated companies:
• Careseng Cancer Institute Inc. • Pegasus BioPark (Dalian) Co., Ltd.
Pegasus has been offering Pegasus bonds and debentures through its website (http://pegasusbonds.com) and sales agents. According to the company’s website, Pegasus is using the funds raised for cancer therapy clinics, new drug development and to upgrade manufacturing facilities.
The BCSC is concerned that Pegasus is offering these investments when it has not issued a prospectus or registered with the BCSC. Furthermore, BCSC staff have concerns about the returns offered on the Pegasus investments, which are as high as 100% per annum.
The BCSC urges the public to be wary about investing in Pegasus or its associated companies.
The BCSC urges investors, agents, or members of the public who have been approached or have information about Pegasus Pharmaceuticals or any of its associated companies to contact the BCSC inquiries line at 604-899-6854 or 1-800-373-6393 (toll free).
With Mother’s Day just around the corner, I thought it would be a good idea to share my experience from last year. I believe it will give you some ideas on how to make this day special for your family, with the added bonus of helping with your long-term saving and investing goals. Furthermore, planning […]
BCSC staff ambassadors tour the province, helping people to protect themselves from fraud and unsuitable investments. Our goal is to enable BC investors to develop critical thinking skills so they can become more informed of steps they should take to protect themselves when investing. Where we are this month Duncan Be Fraud Aware seminar June […]